Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children.
about
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)Evolution of stimulants to treat ADHD: transdermal methylphenidateEfficacy of Psychostimulant Drugs for Cocaine DependenceLisdexamfetamine Dimesylate: Prodrug Delivery, Amphetamine Exposure and Duration of EfficacyA review of long-acting medications for ADHD in CanadaSingle- and multiple-dose pharmacokinetics of an oral once-a-day osmotic controlled-release OROS (methylphenidate HCl) formulationChronic administration of methylphenidate produces neurophysiological and behavioral sensitizationTreating attention-deficit/hyperactivity disorder beyond symptom control alone in children and adolescents: a review of the potential benefits of long-acting stimulantsPresent and future pharmacotherapeutic options for adult attention deficit/hyperactivity disorder.The Amygdala's Neurochemical Ratios after 12 Weeks Administration of 20 mg Long-acting Methylphenidate in Children with Attention Deficit and Hyperactivity Disorder: A Pilot Study Using (1)H Magnetic Resonance Spectroscopy.Absorption, distribution, metabolism and excretion pharmacogenomics of drugs of abuse.Advances in the pharmacotherapy of attention-deficit-hyperactivity disorder: focus on methylphenidate formulations.Effect of methylphenidate on attention in apathetic AD patients in a randomized, placebo-controlled trial.Drug Holidays From ADHD Medication: International Experience Over the Past Four Decades.New methylphenidate formulations for the treatment of attention-deficit/hyperactivity disorder.Efficacy, safety and variability in pharmacotherapy for adults with attention deficit hyperactivity disorder: a meta-analysis and meta-regression in over 9000 patients.Ethylphenidate as a selective dopaminergic agonist and methylphenidate-ethanol transesterification biomarker.The Dopamine Dilemma-Part II: Could Stimulants Cause Tolerance, Dependence, and Paradoxical Decompensation?Understanding the effects of stimulant medications on cognition in individuals with attention-deficit hyperactivity disorder: a decade of progressSingle-dose pharmacokinetics of methylphenidate extended-release multiple layer beads administered as intact capsule or sprinkles versus methylphenidate immediate-release tablets (Ritalin(®)) in healthy adult volunteers.Methylphenidate treatment beyond adolescence maintains increased cocaine self-administration in the spontaneously hypertensive rat model of attention deficit/hyperactivity disorder.Efficacy and safety of modafinil film-coated tablets in children and adolescents with or without prior stimulant treatment for attention-deficit/hyperactivity disorder: pooled analysis of 3 randomized, double-blind, placebo-controlled studies.The Diagnosis and Management of Attention-Deficit/Hyperactivity Disorder in Pediatric Patients.A pharmacokinetic model of oral methylphenidate in the rat and effects on behavior.Descending glutamatergic pathways of PFC are involved in acute and chronic action of methylphenidateAcute and chronic methylphenidate alters prefrontal cortex neuronal activity recorded from freely behaving ratsAcute and chronic methylphenidate dose-response assessment on three adolescent male rat strains.Application of Physiologically Based Absorption Modeling to Characterize the Pharmacokinetic Profiles of Oral Extended Release Methylphenidate Products in AdultsOsmotic, controlled-release methylphenidate for the treatment of ADHD.Targeting the dopamine system in the treatment of attention-deficit/hyperactivity disorder.Methylphenidate (Ritalin): behavioral studies in the rat.Psychopharmacology: concepts and opinions about the use of stimulant medications.Plasma and brain concentrations of oral therapeutic doses of methylphenidate and their impact on brain monoamine content in mice.Differentiation of rodent behavioral phenotypes and methylphenidate action in sustained and flexible attention tasksMethylphenidate for Treating ADHD: A Naturalistic Clinical Study of Methylphenidate Blood Concentrations in Children and Adults With Optimized Dosage.Sex Differences in the Physiological and Behavioral Effects of Chronic Oral Methylphenidate Treatment in RatsEmerging association between addictive gaming and attention-deficit/hyperactivity disorder.An integrated clinical pharmacology approach for deriving dosing recommendations in a regulatory setting: review of recent cases in psychiatry drugs.A review of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD).Model-Based Approach for Optimizing Study Design and Clinical Drug Performances of Extended-Release Formulations of Methylphenidate for the Treatment of ADHD.
P2860
Q22061981-C785116B-F324-4305-A50F-B5BC0AD64C0DQ22252903-82F487D7-94DD-4BDB-A44A-B6D7F9496052Q24239994-55EBC62B-C890-43F2-A75D-BCC9EAB327E7Q26750486-F4A96ADB-16FD-455F-878F-DFBEB3EF335BQ28263326-CB075E99-7C40-472A-B7DC-3212E404D1C5Q28376544-7A8FFC00-3DC3-4133-BFB3-3DFA90461342Q30544583-3C1A55E1-7B5D-4EBA-8262-13A154E205BBQ33746664-A09024E0-1266-4F49-866E-C6E9ED88AFEFQ33945438-D50A4C1B-EBA8-4CEF-9970-0FBDB7A72E22Q34129852-7273E8D3-639F-4A18-94ED-CDD74C1A74E6Q34165511-66C6BC35-ADA8-4327-BDE5-1C677AC6C357Q34273853-16A71835-C7D7-4456-9256-817507CA5FA6Q34380997-D31D4BF3-669F-4722-BB40-1789B7C92867Q34440332-BC07047D-371C-453E-B751-80C319DDD15FQ34468658-37B7F678-D34C-4722-92E9-5971D9FC428EQ34497314-E399C5FE-071B-4E20-A5E0-DA632FF95FCAQ34543628-D539CA1D-9EF8-404A-A040-364432AE1212Q34564052-CF4B3783-35B1-4A8F-A46E-6DAE9CB0758DQ34661181-40E511AF-C0A5-4071-B6A9-2F6000CB88D4Q34719368-6D698D6D-CC09-41E8-912C-5299D5F4C5FDQ35205459-B9E02C11-15AC-42D4-8808-0777354E915BQ35574482-94AC630E-541C-4F01-B75D-5342AA4EF221Q35666033-F982ED4C-0FD7-457F-A40E-94FCEE6B2A29Q35709161-B9ACFB74-C966-4FC2-8898-A382DABAA966Q35734099-EC05CC6A-9F41-4065-A80A-598E9535A17DQ35801356-4942D1BD-55EE-4043-8FBB-8424A31C2AC1Q36102864-5FD1EAED-FF5F-4193-AB13-552413962155Q36159334-F87F80AE-99EE-444F-BA12-2B5F35F9795CQ36613947-39C2A971-300B-4EF1-BAFC-FC00240C0594Q36787333-8A175790-6B2A-42DB-9626-9AC7D1CD88BEQ36799664-F02C690F-076F-4119-A813-D082D98CADCFQ37189436-BB6A5D67-7D78-4327-A532-AD5E4A4E3AA5Q37438542-BAA864D7-A6A5-42A0-94E6-7ABB659A5B9BQ37451921-8872DF11-81D7-47AC-9AFB-AB9AE05404AAQ37685508-959EAC30-2EFD-4FF9-9BE2-9DF4B8AEDFFEQ37723437-65B59DB5-71D6-4642-B973-E95C10B08ABFQ38030488-FAEEE772-80B1-4389-B4EE-9DA06314C628Q38120678-84079BD9-8F00-4615-BF89-27A7A426A59FQ38164670-12BE25B6-612B-4342-839B-4DBFB166D6F9Q38859853-EBE3511D-03B4-4556-973C-7C777C14FD8E
P2860
Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Acute tolerance to methylpheni ...... activity disorder in children.
@ast
Acute tolerance to methylpheni ...... activity disorder in children.
@en
type
label
Acute tolerance to methylpheni ...... activity disorder in children.
@ast
Acute tolerance to methylpheni ...... activity disorder in children.
@en
prefLabel
Acute tolerance to methylpheni ...... activity disorder in children.
@ast
Acute tolerance to methylpheni ...... activity disorder in children.
@en
P2093
P1476
Acute tolerance to methylpheni ...... activity disorder in children.
@en
P2093
Shoulson I
Williams L
P304
P356
10.1016/S0009-9236(99)70038-X
P407
P577
1999-09-01T00:00:00Z